Silver Book Fact

Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.

Campbell C, Kipnes M, Stouch B, et al. Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy. Pain. 2012; 153(9): 1815-23. http://www.ncbi.nlm.nih.gov/pubmed/22683276

Reference

Title
Randomized Control Trial of Topical Clonidine for Treatment of Painful Diabetic Neuropathy
Publication
Pain
Publication Date
2012
Authors
Campbell C, Kipnes M, Stouch B, et al
Volume & Issue
Volume 153, Issue 9
Pages
1815-23
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Use of stem cells to create neurons could enable the study of the response of human cells to new drugs in vitro, early in the drug development process.  
  • In individuals with persistent low back pain, tanezumab, a humanized anti-nerve growth factor antibody, showed clinical and statistical analgesic efficacy that was superior to placebo and naproxen.  
  • Targeting A-type K+ channels in primary sensory neurons could provide a novel mechanism-based therapy for the treatment of bone cancer pain–one of the most severe types of chronic pain.  
  • A meta-analysis of pscychological interventions for chronic low back pain found small but statistically significant effects for all interventions for as long as 5 years.  
  • Topical clonidine gel significantly reduces foot pain in patients with painful diabetic neuropathy.